| Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938, 2015 | 908 | 2015 |
| The MLL recombinome of acute leukemias in 2017 C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284, 2018 | 637 | 2018 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 549 | 2013 |
| New insights to the MLL recombinome of acute leukemias C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ... Leukemia 23 (8), 1490-1499, 2009 | 497 | 2009 |
| Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non–small-cell lung carcinoma D Lebanony, H Benjamin, S Gilad, M Ezagouri, A Dov, K Ashkenazi, ... Journal of clinical oncology 27 (12), 2030-2037, 2009 | 494 | 2009 |
| Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ... Journal of Experimental Medicine 208 (5), 901-908, 2011 | 391 | 2011 |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 389 | 2008 |
| Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002 J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ... American Society of Clinical Oncology, 2014 | 386 | 2014 |
| The landscape of somatic mutations in Down syndrome–related myeloid disorders K Yoshida, T Toki, Y Okuno, R Kanezaki, Y Shiraishi, A Sato-Otsubo, ... Nature genetics 45 (11), 1293-1299, 2013 | 385 | 2013 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 378 | 2010 |
| The public repository of xenografts enables discovery and randomized phase II-like trials in mice EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ... Cancer cell 29 (4), 574-586, 2016 | 313 | 2016 |
| Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21 L Rainis, D Bercovich, S Strehl, A Teigler-Schlegel, B Stark, J Trka, ... Blood 102 (3), 981-986, 2003 | 311 | 2003 |
| Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome S Malinge, S Izraeli, JD Crispino Blood, The Journal of the American Society of Hematology 113 (12), 2619-2628, 2009 | 280 | 2009 |
| Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ... Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014 | 277 | 2014 |
| Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children … G Cario, M Zimmermann, R Romey, S Gesk, I Vater, J Harbott, ... Blood, The Journal of the American Society of Hematology 115 (26), 5393-5397, 2010 | 276 | 2010 |
| The expression of three genes in primary non–small cell lung cancer is associated with metastatic spread to the brain H Grinberg-Rashi, E Ofek, M Perelman, J Skarda, P Yaron, M Hajdúch, ... Clinical Cancer Research 15 (5), 1755-1761, 2009 | 235 | 2009 |
| The SIL gene is required for mouse embryonic axial development and left–right specification S Izraeli, LA Lowe, VL Bertness, DJ Good, DW Dorward, IR Kirsch, ... Nature 399 (6737), 691-694, 1999 | 233 | 1999 |
| IKZF1 defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia M Stanulla, E Dagdan, M Zaliova, JP Bourquin, B Bornhauser Journal of Clinical Oncology 36 (12), 1240-1249, 2018 | 228 | 2018 |
| MiR-125 in normal and malignant hematopoiesis L Shaham, V Binder, N Gefen, A Borkhardt, S Izraeli Leukemia 26 (9), 2011-2018, 2012 | 201 | 2012 |
| STIL is required for centriole duplication in human cells J Vulprecht, A David, A Tibelius, A Castiel, G Konotop, F Liu, F Bestvater, ... Journal of cell science 125 (5), 1353-1362, 2012 | 195 | 2012 |
